| NANO Nuclear Announces Participation in Several Investor Conferences |
Globe Newswire |
10/07 |
08:30 |
| Achieve Life Sciences Appoints Kaitlyn Tuson as Senior Vice President, Marketing and Communications |
Globe Newswire |
10/07 |
08:30 |
| Alliance Entertainment Announces October 2026 Investor Conference Schedule |
Globe Newswire |
10/07 |
08:30 |
| Beeline to Host Stakeholder Update Call on Q3 2026 Financial Results |
Globe Newswire |
10/07 |
08:30 |
| Mint Enters into OEM Supply and License Agreement with Ireland-based Centridex to Expand into Europe |
Globe Newswire |
10/07 |
08:30 |
| Apryse Expands Document SDKs to Reduce Custom Development Across AI, Editing and Capture Workflows |
Globe Newswire |
10/07 |
08:29 |
| Progyny, Inc. Selling Season Pacing to Record Level, Revealing Critical Insights on Latest Market Dynamics |
Globe Newswire |
10/07 |
08:28 |
| American Service Partners Launches National Home Services Platform, Acquiring Brands From Platform Partner Holdings and Exuma Capital |
Globe Newswire |
10/07 |
08:17 |
| FDA Grants SeaStar Medical Breakthrough Device Designation for its SCD Therapy for the Treatment of Hyperinflammation in Adult Patients with Sepsis or a Septic Condition |
Globe Newswire |
10/07 |
08:16 |
| FuelCell Energy Announces Chief Financial Officer Transition |
Globe Newswire |
10/07 |
08:15 |
| Byondis to Profile Potential of Platform Technologies at World ADC San Diego, Advancing Strategy to Lead the Antibody-Drug Conjugate Field |
Globe Newswire |
10/07 |
08:04 |
| Safe Pro Expects Record 2,300% Revenue Growth in Q3 2026 Driven by Multiple Government Contracts for AI-Powered Threat Detection and Mapping |
Globe Newswire |
10/07 |
08:02 |
| Skyworks Si829x Isolated Safety Gate Driver Qualified and Ready for Customer Evaluation |
Globe Newswire |
10/07 |
08:01 |
| Aptean Launches Ascent, an Outcome-Based AI Partnership Built on Measurable Business Results |
Globe Newswire |
10/07 |
08:00 |
| Bexorg Awarded Up to $28.3 Million from ARPA-H to Advance Human Brain Translational Pharmacology for CNS Drug Development |
Globe Newswire |
10/07 |
08:00 |
| Erin Schaefer, Former Google/YouTube Senior Executive, Joins Roundtable Board to Help Guide Premium-Media OS Growth |
Globe Newswire |
10/07 |
08:00 |
| Rezera Announces Positive RESOLVE-2 Phase 2 Clinical Trial Results Demonstrating Favorable Safety and Tolerability Profile for Ruvonoflast in Combination with Semaglutide |
Globe Newswire |
10/07 |
08:00 |
| Madison Realty Capital Provides Loan for Hotel Washington in Washington, D.C. |
Globe Newswire |
10/07 |
08:00 |
| Healthrise Identifies Key Factors for a Faster, More Efficient EHR Go-Live |
Globe Newswire |
10/07 |
08:00 |
| Kaléo Awarded $96.1 Million BARDA Contract to Advance 2-PAM Auto-Injector for U.S. Chemical Threat Preparedness |
Globe Newswire |
10/07 |
08:00 |
| Pacira BioSciences and Caregiver Action Network Announce New Survey on Gaps in Preparing Families for Postsurgical Recovery at Home |
Globe Newswire |
10/07 |
08:00 |
| Nuclear Waste Innovator Deep Isolation to Present at Three Upcoming Investor Conferences |
Globe Newswire |
10/07 |
08:00 |
| Atsena Presents Positive Preliminary Safety and Efficacy Results from Parts A and B of the Phase 1/2/3 LIGHTHOUSE Trial Evaluating ATSN-201 in Patients with X-linked Retinoschisis |
Globe Newswire |
10/07 |
08:00 |
| Esperion Reaches Settlement Agreement with Sixth ANDA Filer Not to Market Generic Version of NEXLETOL® (bempedoic acid) & NEXLIZET® (bempedoic acid & ezetimibe) Prior to April 19, 2040 |
Globe Newswire |
10/07 |
08:00 |
| Melissa Introduces Elected Officials Data for More Effective Government Relations and Advocacy |
Globe Newswire |
10/07 |
08:00 |
